HOME >> MEDICINE >> NEWS
Prostate cancer treatment increases risk of diabetes and heart disease

BOSTON -- A treatment mainstay for prostate cancer puts men at increased risk for diabetes and cardiovascular disease, according to a large observational study published in the Sept. 20 Journal of Clinical Oncology.

"Men with prostate cancer have high five-year survival rates, but they also have higher rates of non-cancer mortality than healthy men," says study author Nancy Keating, MD, MPH, assistant professor of health care policy and of medicine at Harvard Medical School. "This study shows that a common hormonal treatment for prostate cancer may put men at significant risk for other serious diseases. Patients and physicians need to be aware of the elevated risk as they make treatment decisions."

The principal systemic therapy for prostate cancer involves blocking testosterone production. This is done either by removal of the testes (bilateral orchiectomy), or more commonly, by regular injections of a gonadotropin-releasing hormone (GnRH) agonist drug. GnRH agonists are the main therapy for metastatic prostate cancer and may also improve survival for some men with locally-advanced cancers.

However, little is known about the efficacy of GnRH agonists in treating men with less-advanced local or regional prostate cancer, many of whom receive this therapy. Earlier studies have found GnRH agonists to be associated with obesity and insulin resistance, a precursor to diabetes.

"Our study found that men with local or regional prostate cancer receiving a GnRH agonist had a 44 percent higher risk of developing diabetes and a 16 percent higher risk of developing coronary heart disease than men who were not receiving hormone therapy," says Keating, who is also a physician at Brigham and Women's Hospital.

"Doctors should think twice about prescribing GnRH agonists in situations for which studies have not demonstrated improved survival until we better understand the risks of treatment," says co-author Matthew Smith, MD, PhD
'"/>

Contact: Leah Gourley
public_affairs@hms.harvard.edu
617-432-0442
Harvard Medical School
18-Sep-2006


Page: 1 2

Related medicine news :

1. Prostate cancer patients see high survival rates with seed implants
2. Prostate cancer research may be faster with PSA endpoints
3. Prostate treatment decisions based on perception more than fact
4. Prostate cancer test affected by demographic and lifestyle factors
5. Prostate cancer therapy - study suggests new molecular screening theory
6. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
7. Survival differences by race most apparent in advanced stages of breast cancer
8. Stomach cancer rate set to fall further 25 percent over next decade
9. MRI finds breast cancer before it becomes dangerous
10. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
11. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2018)... ... , ... Alice Branton shared her personal story on NBC Daytime about how ... Penacoli. , With all the medical advancements over the last hundred years, vitamin ... health problem worldwide irrespective of age, location, ethnicity, and gender. Even in those residing ...
(Date:8/31/2018)... HANOVER (PRWEB) , ... August 31, 2018 , ... ... expanded its neuroimaging capabilities with the addition of an MRI Simulator. In the ... (MRI) scan including sounds. By engaging in this mock scan experience, research participants ...
(Date:8/31/2018)... ... August 31, 2018 , ... Rudina Thanasi, ... of a biofield energy treated nutraceutical to improve overall immunity and to combat ... and blood, as well as, inflammation. The following data was reported:, ...
(Date:8/31/2018)... ... August 31, 2018 , ... ... Therapeutics Inc.’s “hit” list. The company, a small molecule drug discovery and ... in September 2017 with a mission to develop a first-in-class therapeutic targeting ...
(Date:8/29/2018)... ... August 29, 2018 , ... ... What You Need to Know” to provide information on the similarities and differences ... lays out the similarities, and, more importantly, differences between vaping and smoking. To ...
Breaking Medicine News(10 mins):
(Date:9/13/2018)... ... September 13, 2018 , ... NCPDP ... to test and ensure correct implementation of the NCPDP SCRIPT Standard Version 2017071 ... important functionality and transactions identified by the industry as vital enhancements in improving ...
(Date:9/12/2018)... ... September 12, 2018 , ... ... Express Surveys as part of its Population Engage patient experience suite. Express ... from patients, giving the provider organization a wealth of strategic and tactical knowledge ...
(Date:9/12/2018)... ... September 13, 2018 , ... Donaldson Plastic Surgery has been included on ... Business First's Fast 50 list of central Ohio's fastest growing businesses. The plastic surgery ... of 81 percent. It is the only medical practice and plastic surgery office to ...
Breaking Medicine Technology:
Cached News: